The content is available as a PDF (438.1 KB).
How important is the assessment of soluble ACE-2 in COVID-19?
Manuel Rojas
Yeny Acosta-Ampudia
Diana M Monsalve
Carolina Ramírez-Santana
Juan-Manuel Anaya
Corresponding author: Juan-Manuel Anaya, MD, PhD. Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad Del Rosario, Carrera 26-63-B-51, 110010 Bogota, Colombia., E-mail juan.anaya@urosario.edu.co
Received 2020 Oct 30.
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)